Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2012
07/04/2012EP2470546A1 HEXAHYDROOXAZINOPTERINE COMPOUNDS FOR USE AS mTOR INHIBITORS
07/04/2012EP2470545A1 Anhydrate forms of a pyridine derivative
07/04/2012EP2470544A1 Condensed quinolines as protein kinase modulators
07/04/2012EP2470542A2 Preparation of sitagliptin and salts thereof
07/04/2012EP2470541A1 Raf inhibitor compounds and methods of use thereof
07/04/2012EP2470540A1 Novel forms of a multicyclic compound
07/04/2012EP2470539A1 Raf inhibitor compounds and methods of use thereof
07/04/2012EP2470538A1 Raf inhibitor compounds and methods of use thereof
07/04/2012EP2470537A2 Heterocyclic compounds as janus kinase inhibitors
07/04/2012EP2470536A1 Methylpyrrolopyrimidinecarboxamides
07/04/2012EP2470534A1 Jak inhibition blocks rna interference associated toxicities
07/04/2012EP2470533A1 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors
07/04/2012EP2470532A1 1h-pyrazolo [ 3, 4-b]pyridine compounds for inhibiting raf kinase
07/04/2012EP2470531A1 Methylpyrrolopyridinecarboxamides
07/04/2012EP2470530A1 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
07/04/2012EP2470529A1 A 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivate with substantially undefined crystal shape for preparing said 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative
07/04/2012EP2470528A1 Compounds and compositions as protein kinase inhibitors
07/04/2012EP2470526A1 Compounds and compositions as protein kinase inhibitors
07/04/2012EP2470525A1 Piperidine derivatives used as orexin antagonists
07/04/2012EP2470524A1 Pyrrolidine derivatives as nk3 receptor antagonists
07/04/2012EP2470523A1 5-methyl-piperidine derivatives as orexin receptor antagonists for the treatment of sleep disorder
07/04/2012EP2470522A1 Np-1 antagonists and their therapeutic use
07/04/2012EP2470520A1 Chromone derivatives, a process for their preparation and their therapeutic applications
07/04/2012EP2470519A1 Treatment of macular degeneration
07/04/2012EP2470515A2 Desferrithiocin polyether analogues and uses thereof
07/04/2012EP2470514A1 Pseudodipeptides as mmp inhibitors
07/04/2012EP2470512A1 Aromatase inhibitor
07/04/2012EP2470511A1 Raf inhibitor compounds and methods of use thereof
07/04/2012EP2470510A1 Substituted imidazole derivatives for treatment of alzheimers disease
07/04/2012EP2470508A1 Cannabinoid receptor modulators
07/04/2012EP2470506A1 Kinase inhibitors
07/04/2012EP2470505A2 Polymorphic forms of manidipine
07/04/2012EP2470502A1 Tetra-substituted heteroaryl compounds and their use as mdm2 and/or mdm4 modulators
07/04/2012EP2470500A2 Tetracycline compounds
07/04/2012EP2470499A1 Novel colchicine derivatives, methods and uses thereof
07/04/2012EP2470498A1 Carbocyclic glyt1 receptor antagonists
07/04/2012EP2470270A1 Compounds for treatment of inflammation
07/04/2012EP2470269A1 Use of the combination of teriflunomide and glatiramer acetate for treating multiple sclerosis
07/04/2012EP2470268A1 Purine-targeted diagnosis and therapy of wounds
07/04/2012EP2470223A2 Sprayable polymers as adhesion barriers
07/04/2012EP2470217A1 Targeting pax2 for the treatment of breast cancer
07/04/2012EP2470214A1 Method of treating frailty
07/04/2012EP2470212A1 Method of treatment of philadelphia chromosome positive leukaemia
07/04/2012EP2470186A2 Synthesis and isolation of dendrimer systems
07/04/2012EP2470185A1 Pharmaceutical compositions for treating ibd
07/04/2012EP2470184A1 Chemical induction of lactation
07/04/2012EP2470183A2 Heterocyclic amide compounds as protein kinase inhibitors
07/04/2012EP2470182A1 Synthesis of a neurostimulative piperazine
07/04/2012EP2470181A1 Method of treating compulsive disorders with alpha-2b adrenergic receptor agonists
07/04/2012EP2470180A2 Gaba release-regulating agent in cerebellum
07/04/2012EP2470179A2 Sustained release delivery systems for the prevention and treatment of head and neck cancers
07/04/2012EP2470178A1 Antimycotic pharmaceutical composition
07/04/2012EP2470177A1 Combination therapy for treating proliferative diseases
07/04/2012EP2470176A1 Composition and method for treating cognitive impairments in down syndrom subjects
07/04/2012EP2470175A1 Fulvic acid compositions and their use
07/04/2012EP2470174A1 Use of faa and its derivatives in cosmetics and dermatology
07/04/2012EP2470173A1 Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors
07/04/2012EP2470172A1 Pharmaceutical formulations and methods of use
07/04/2012EP2470171A1 Antimicrobial amino-salicylic acid derivatives
07/04/2012EP2470170A2 Use of metformin in cancer treatment and prevention
07/04/2012EP2470169A2 Methods for treatment of a sarcoma using an epimetabolic shifter (coenzyme q10)
07/04/2012EP2470168A1 Methods for the prevention and treatment of cerebral ischemia
07/04/2012EP2470157A1 Hot-melt extruded compositions containing plant-derived phenolic materials and processes for the preparation thereof
07/04/2012EP2470021A1 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
07/04/2012EP2470020A1 Benzodiazepinone compounds and methods of treatment using same
07/04/2012EP2470019A1 Compositions for delivery of insoluble agents
07/04/2012EP2470015A1 Methods for treating acute acoustic trauma
07/04/2012EP2470014A1 Hiv integrase inhibitors
07/04/2012EP2470013A1 Compounds that treat malaria and prevent malaria transmission
07/04/2012EP2470011A1 An automated method and system for the analysis of total dietary fiber
07/04/2012EP2285784B1 2-methyl-1-(phenylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazole as 5-hydroxytryptamine-6 ligand
07/04/2012EP2262799B1 Pyridine compounds
07/04/2012EP2262782B1 Novel aminomethyl benzene derivatives
07/04/2012EP2257555B1 Thieno[2,3-d]-pyrimidine-4(3h)-one compounds with antifungal properties and process thereof
07/04/2012EP2238142B1 Macrocyclic indoles as hepatitis c virus inhibitors
07/04/2012EP2229150B1 Systems and methods for delivery of materials
07/04/2012EP2178888B1 Proteasome inhibitors
07/04/2012EP2120950B1 Use of quinoline derivatives in the treatment of pain
07/04/2012EP2062887B1 Aminopyridine derivative having aurora a-selective inhibitory activity
07/04/2012EP2029746B1 Compositions and methods for sirna inhibition of angiogenesis
07/04/2012EP2015748B1 A C-Kit kinase inhibitor for use in the treatment of gastrointestinal stromal tumor or mastocytosis
07/04/2012EP2004649B1 Phenolic hydrazone macrophage migration inhibitory factor inhibitors
07/04/2012EP1989206B1 Inhibitors of e1 activating enzyme
07/04/2012EP1945256B1 Methods and compositions for improving wound repair
07/04/2012EP1942938B1 Use of oligouronates for treating mucus hyperviscosity
07/04/2012EP1928436B1 Application system for a plaster containing an active ingredient and a controlled-release agent for said active ingredient
07/04/2012EP1879654B1 Pharmaceutical combination comprising an antifungal agent and an active substance selected especially from eugenol and carvacrol
07/04/2012EP1874306B1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
07/04/2012EP1868569B1 Liquid aqueous dosage forms for sub-lingual or nasal applications of active agents with amino groups
07/04/2012EP1863793B1 Hepatitis c virus inhibitors
07/04/2012EP1858864B1 Stabilized compositions of volatile alkylating agents and methods of using thereof
07/04/2012EP1817036B1 Modulators of muscarinic receptors
07/04/2012EP1786799B1 Novel phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase
07/04/2012EP1786759B1 Novel derivatives of 3,5-seco-4-norcholestane and use thereof
07/04/2012EP1756034B1 Antibiotic compound
07/04/2012EP1744781B1 Treatment of infectious diseases
07/04/2012EP1689233B1 Bicyclic inhibitors of mek
07/04/2012EP1624869B1 Dosage form containing pantoprazole as active ingredient
07/04/2012EP1555944B1 Packaged antimicrobial medical device and method of preparing same
07/04/2012EP1550662B1 Adenine compound and use thereof
1 ... 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 ... 7860